NCT02592096

Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol

A Single Dose Phase I Clinical Study of Pazufloxacin Mesilate Ear Drops for the Patients With Otitis Media

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (estimated)
• Sponsor: Lee's Pharmaceutical Limited · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

To investigate the safety, tolerance, dynamic percolation model of single dose usage pazufloxacin mesilate ear drops for patients with acute suppurative otitis media or chronic suppurative otitis media

Conditions

• Otitis Media

Interventions

Type	Name	Description
DRUG	0.1% Pazufloxacin Mesilate Ear Drops
DRUG	0.3% Pazufloxacin Mesilate Ear Drops
DRUG	0.5% Pazufloxacin Mesilate Ear Drops
DRUG	Pazufloxacin mesilate injection

Timeline

• Start date: 2015-07-01
• Primary completion: 2016-01-01
• Completion: 2016-02-01
• First posted: 2015-10-30
• Last updated: 2015-10-30

Locations

1 site across 1 country: China